|
End-of-day quote
Bulgaria S.E.
21/10/2026
|
5-day change | 1st Jan Change | ||
| 3.080 EUR | +1.32% |
|
+16.67% | +116.21% |
| 21/09 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 28/08 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 310.2Cr 186.3Cr 166.02Cr 153.7Cr 139.1Cr 262.06Cr 18TCr 265.17Cr 1.84TCr 723.1Cr 9.24TCr 698.88Cr 684.33Cr 29TCr | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 364.32Cr 218.81Cr 194.98Cr 180.52Cr 163.37Cr 307.79Cr 21TCr 311.44Cr 2.16TCr 849.28Cr 11TCr 820.83Cr 803.74Cr 35TCr | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +1.32% | ||
| 1 week | +16.67% | ||
| Current month | +18.92% | ||
| 1 month | +22.22% | ||
| 3 months | +62.53% | ||
| 6 months | +79.07% | ||
| Current year | +116.21% |
| 1 week | 2.74 |  | 3.09 |
| 1 month | 2.46 | | 3.09 |
| Current year | 1.41 | | 3.09 |
| 1 year | 1.34 | | 3.09 |
| 3 years | 0.94 | | 3.09 |
| 5 years | 0.67 | | 3.09 |
| 10 years | 0.41 | | 3.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/09/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/09/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.32% | +16.67% | +122.28% | +158.81% | 183.88Cr | |
| -2.21% | +7.45% | -38.37% | +10.25% | 1.62TCr | |
| +15.09% | +2.13% | +10.64% | -17.34% | 753.17Cr | |
| -0.75% | +4.31% | -11.08% | +0.62% | 645.48Cr | |
| -3.23% | +3.31% | -13.99% | +3.77% | 647.88Cr | |
| -3.77% | +2.98% | -51.33% | -34.78% | 628.19Cr | |
| -0.58% | +1.50% | +1.22% | -3.86% | 467.91Cr | |
| +1.99% | +4.88% | -33.71% | +3.80% | 351.45Cr | |
| -0.93% | -4.54% | -1.69% | -21.83% | 311.15Cr | |
| -3.36% | +1.10% | -15.66% | -11.35% | 327.9Cr | |
| Average | +0.36% | +4.36% | -3.17% | +8.81% | 593.44Cr | |
| Weighted average by Cap. | +0.36% | +4.50% | -16.34% | +0.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 213.95Cr 128.5Cr 114.5Cr 106.01Cr 96Cr 180.75Cr 12TCr 182.89Cr 1.27TCr 498.73Cr 6.37TCr 482.03Cr 471.99Cr 20TCr | 263.27Cr 158.12Cr 140.9Cr 130.45Cr 118.05Cr 222.41Cr 15TCr 225.05Cr 1.56TCr 613.71Cr 7.84TCr 593.15Cr 580.8Cr 25TCr |
| Net income | 7.78Cr 4.68Cr 4.17Cr 3.86Cr 3.49Cr 6.58Cr 441.2Cr 6.65Cr 46Cr 18Cr 231.91Cr 18Cr 17Cr 739Cr | 13Cr 8.02Cr 7.15Cr 6.62Cr 5.99Cr 11Cr 756.76Cr 11Cr 79Cr 31Cr 397.78Cr 30Cr 29Cr 1.27TCr |
| Net Debt | 44Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.52TCr 38Cr 263.89Cr 103.54Cr 1.32TCr 100.08Cr 98Cr 4.22TCr | 54Cr 33Cr 29Cr 27Cr 24Cr 46Cr 3.07TCr 46Cr 321.56Cr 126.18Cr 1.61TCr 121.95Cr 119.41Cr 5.14TCr |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | €3.080 | +1.32% | 5,937 |
| 20/26/20 | €3.040 | +0.66% | 36,196 |
| 19/26/19 | €3.020 | +3.42% | 1,08,125 |
| 16/26/16 | €2.920 | +5.42% | 1,39,942 |
| 15/26/15 | €2.770 | -0.72% | 15,112 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
